Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Neuropilin-1–Platelet-derived growth factor receptor beta (NRP-1–PDGFRβ) complex is a functional protein assembly that plays a pivotal role in vascular biology and tissue repair. Neuropilin-1 (NRP-1) acts as a versatile co-receptor, enhancing the signaling of Platelet-derived growth factor receptor beta (PDGFRβ) in response to ligands such as PDGF-BB and PDGF-D [1, 3, 5]. This interaction is crucial for the migration and proliferation of mesenchymal cells, including vascular smooth muscle cells and pericytes, which are essential for blood vessel maturation and stabilization [1, 4]. In the context of oncology, particularly in hepatocellular carcinoma, the formation of this complex has been linked to vascular normalization, a process that improves blood flow and immune cell infiltration into tumors [7, 10]. Conversely, overactivation of the complex is associated with pathological fibrosis and tumor progression in various cancers [3, 14, 15]. Therapeutic agents like Lenvatinib have been shown to modulate the formation of this complex, shifting NRP-1 from its association with VEGFR2 to PDGFRβ to promote a more stable vascular phenotype [7]. Understanding the dynamics of the NRP-1–PDGFRβ complex is vital for developing targeted therapies that balance anti-angiogenic effects with vascular stabilization.
Modulation of receptor heterodimerization and downstream signaling pathways (e.g., Crkl-C3G-Rap1 or p130Cas) to regulate vascular stability, pericyte recruitment, and mesenchymal cell activity.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuropilin-1–Platelet-derived growth factor receptor beta complex (NRP-1–PDGFRβ complex).